PGP and breast cancer: In most cell lines tested, SP cells were completely and consistently diminished by addition of the specific BCRP inhibitor Ko143 (Figure 2A), but not by the Pgp inhibitor verapamil or FTC (data not shown), suggesting that BCRP has a dominant role in defining SP cells in BC.